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Original research article—Basic science
Streptococcus salivarius: A Potential Salivary Biomarker for 
Orofacial Granulomatosis and Crohn’s Disease?
Rishi M. Goel, MBBS,* Erica M. Prosdocimi, PhD,† Ariella Amar, MSc,‡ Yasmin Omar, MRes,‡  
Michael P. Escudier, MD, FDSRCS,§ Jeremy D. Sanderson, MD, FRCP,¶ William G. Wade, PhD,†,  and  
Natalie J. Prescott, PhD‡
Background: Orofacial granulomatosis (OFG) is a rare disease characterised by chronic, noncaseating, granulomatous inflammation primarily 
affecting the oral cavity. Histologically, it is similar to Crohn’s disease (CD), and a proportion of patients have both OFG and CD. The cause of 
OFG remains elusive, but it has been suggested that microbial interactions may be involved. The aim of this study was to compare the salivary 
microbial composition of subjects with OFG and/or CD and healthy controls.
Methods: Two hundred sixty-one subjects were recruited, of whom 78 had OFG only, 40 had both OFG and CD, 97 had CD only with no oral 
symptoms, and 46 were healthy controls. Bacterial community profiles were obtained by sequencing the V1-V3 region of the 16S rRNA gene.
Results: There were no differences in richness or diversity of the salivary bacterial communities between patient groups and controls. The rel-
ative abundance of the Streptococcus salivarius group was raised in patients with OFG or CD only compared with controls, whereas that of the 
Streptococcus mitis group was lower in CD compared with both OFG and controls. One S. salivarius oligotype made the major contribution to 
the increased proportions seen in patients with OFG and CD.
Conclusions: The salivary microbiome of individuals with OFG and CD was similar to that found in health, although the proportions of 
S. salivarius, a common oral Streptococcus, were raised. One specific strain-level oligotype was found to be primarily responsible for the increased 
levels seen.
Key Words:  Orofacial granulomatosis, microbiota, saliva, Streptococcus
INTRODUCTION
Orofacial granulomatosis (OFG) is a rare chronic dis-
ease characterized by lip swelling and oral inflammation. The 
term was originally used to describe oral signs clinically and 
histologically resembling Crohn’s disease (CD) in patients 
with no apparent disease elsewhere in the gastrointestinal 
tract.1 Crohn’s disease is a chronic, granulomatous, inflamma-
tory condition that can affect any part of the gastrointestinal 
tract but most commonly occurs in the terminal ileum. As the 
mouth is continuous with the gastrointestinal tract and can be 
affected by granulomatous inflammation, the term “oral CD” 
has also been used to describe patients with granulomatous in-
flammation of the oral cavity.
In addition, although a majority of patients with OFG 
without gut symptoms have been shown to have microscopic 
intestinal granulomata, only a relatively small proportion de-
velop gut CD.2, 3 Because it is a rare disorder, the reported ge-
ographical distribution of OFG may be skewed by differences 
in disease classification and reporting. Notwithstanding 
this, the majority of cases have been reported in the United 
Kingdom—particularly Scotland—and OFG seems to occur 
in greater frequency with concurrent CD in Northern Europe 
as compared with the South.4 Males and females seem to be 
affected equally, with the median age of disease onset being 
23 years.2
The clinical features of OFG include recurrent lip 
swelling and oral ulceration. Persistent inflammation can result 
in disfiguring fibrotic disease which, in some cases, causes per-
manent lip swelling refractory to medical therapy that requires 
debulking surgery. Other features include gingival erythema,5 
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mucosal tags, and “cobblestoning” caused by buccal oedema.6 
Being facially disfiguring, the disease carries a significant psy-
chological burden for affected individuals.7
The underlying cause of OFG remains unknown, but it 
is likely to have a multifactorial aetiology. Patients with OFG 
have a high incidence of atopy compared with the general pop-
ulation,8, 9 and dietary antigens including cinnamon and ben-
zoate compounds may trigger disease exacerbations. Excluding 
these antigens from the diet has been found to be effective in 
controlling OFG in up to 25% of individuals and is the first line 
of intervention in management.10, 11 Immunohistochemistical 
analysis of oral biopsies from patients with active OFG 
identified a novel population of subepithelial dendritic B cells 
that expressed IgE,12 supporting the concept that an antigen 
may trigger an immediate hypersensitivity reaction.
Other granulomatous diseases such as sarcoidosis or 
tuberculosis are known to result from infection by specific 
microorganisms. It has been suggested that Mycobacterium 
avium s.s. paratuberculosis (MAP) might play a similar role 
in CD but has yet to be definitively proven.13, 14 Raised levels 
of  antibodies against a mycobacterial stress protein have 
been found in patients with OFG,15 but MAP has not been 
detected in OFG lesions.16, 17 The spirochete Borrelia burg-
dorferi has also been implicated in OFG based on raised an-
tibody levels to the organism and apparent treatment success 
with penicillin,18, 19 but this finding was not confirmed in a 
later study.20
To date, there is no compelling evidence for the role of 
a specific infective organism in OFG. It is possible, however, 
that the initiating event for OFG is an inappropriate immune 
response to a member or members of the normal microbiota 
giving rise to inflammation. This would change the local envi-
ronment by altering oral surfaces and thereby changing coloni-
zation patterns and/or providing serum-derived nutrients that 
enhance the growth of secondary colonizers. The aim of the 
study was to use 16S rRNA gene community profiling to de-
termine the composition of the salivary microbiome in patients 
with OFG only, OFG with concurrent CD, and compare this 
with patients with CD without oral involvement and with 
healthy controls.
MATERIALS AND METHODS
Patients and Controls
Patients attending a specialist OFG clinic in the depart-
ment of Oral Medicine at Guy’s & St. Thomas’ Hospitals, 
London, were recruited over a 2-year period. Patients with CD 
were recruited via IBD clinics at Guy’s & St. Thomas’ Hospitals 
as previously described.21 Control subjects were recruited 
from healthy (no disease) volunteers at Guy’s & St. Thomas’ 
Hospitals. Control subjects were excluded from participating 
if  they reported a history of chronic inflammatory disorder 
including IBD, current gastro-intestinal symptoms, or oral 
disease. Two hundred sixty-one subjects were recruited for the 
study: 40 (18 female) had both OFG and CD (OFG+CD), 78 
(43 female) had oral manifestations only (OFG only), 97 (62 
female) were diagnosed with Crohn’s disease without any oral 
symptoms (CD only), and 46 (33 female) were healthy controls 
(HC). The age of the subjects at the time of collection ranged 
from 16 to 79 years. Each patient provided informed verbal and 
written consent.
The primary inclusion criterion for patients was a con-
firmed history of active or inactive OFG and/or CD. The di-
agnosis of OFG was based on clinical features including lip 
swelling and typical oral ulceration. Where available, histology 
results were also used to support the diagnosis. The diagnosis 
of CD was based on conventional clinical, biochemical, en-
doscopic, histological, and radiological criteria. Patients 
were excluded from the study if  they were being treated with 
antibiotics at the time of sampling.
All patients underwent an oral examination, and the sites 
of involvement and severity of OFG were recorded as part of 
a standardized oral disease activity score (ODAS). Other oral 
findings were also recorded, particularly dental disease, active 
carious disease, and other oral mucosal changes. Where pos-
sible, patients, with their consent, underwent a basic perio-
dontal examination (BPE) to assess for gingival disease. In the 
BPE, the mouth was divided into sextants, and each sextant 
scored from 0 to 4 with 0 indicating no pocketing or bleeding 
in that sextant and 4 indicating advanced periodontitis. The 
scores for each sextant were summed to give a value between 0 
and 24. Basic periodontal examination scores were compared 
between groups. This variable was transformed by categorical 
grouping into 3 classes, and the differences in microbiome com-
position between BPE classes were assessed. Subject groups 
were compared for age and gender distribution. The effect of 
immunosuppressant therapy and antitumor necrosis factor 
(TNF)-α therapy on the microbiome of subjects with OFG was 
determined.
The study was approved by the local Research Ethics 
Committee (Approval No. 12/YH/0172; Yorkshire & The 
Humber REC).
Sample Collection
Whole saliva was collected by asking patients or 
volunteers to spit in a universal container until a minimum 
volume of at least 1  mL had been obtained. Saliva samples 
were immediately placed on ice and then transferred within 
3 hours to a freezer for storage at −70°C. All samples were 
anonymized and coded.
Bacterial Community Profiling
DNA was extracted from the saliva samples by means 
of the Genelute DNA extraction kit (Sigma-Aldrich), and 
16S rRNA genes were amplified by polymerase chain reaction 
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(PCR) with primers 27F (with the YM modification) and 
519R.22, 23 The primers incorporated a unique barcode and 
Roche 454 adapters. Polymerase chain reaction amplicons 
were purified, sized, quantified, and pooled in equimolar 
proportions. Emulsion PCR and unidirectional sequencing of 
the libraries were performed using the Lib-L kit and Roche 454 
GS-FLX Titanium sequencer.
Data Analysis
Preprocessing and analysis of sequences were carried out 
using the mothur analysis suite version 1.36.124 based on the 
Schloss SOP (January 2016). Initial denoising was performed 
using AmpliconNoise algorithm. Subsequently, any sequences 
less than 440 bases in length or that had >2 mismatches in the 
primer, >1 mismatch in barcode regions, and homopolymers 
of >8 bases were removed from the dataset. The remaining 
sequences were trimmed to remove the primers and barcodes 
and aligned to the SILVA 16S rRNA reference alignment.25 An 
additional precluster step was performed in mothur to merge 
sequences with 4 or fewer bases differences. The UChime al-
gorithm,26 as implemented by mothur, was used to identify 
sequence chimeras, which were removed from the analysis. 
Sequences were clustered into Operational Taxonomic Units 
(OTUs) at a sequence dissimilarity distance of 0.015 using an 
average neighbor algorithm and then classified using a Naïve 
Bayesian classifier implemented in mothur with the Human 
Oral Microbiome Database reference dataset v13.2.27 The 
α-diversity of bacterial communities based on OTUs was 
analyzed using approaches implemented by mothur: richness of 
the communities was assessed by the number of observed OTUs 
and the Chao1 richness index; diversity of the communities was 
estimated using the Simpson inverse diversity index. Richness 
and diversity estimates were compared between groups using 
Kruskal Wallis test.
To compare the β diversity of samples based on OTUs, 
the thetaYC metric, which compares community structure by 
accounting for the relative abundance of taxa,28 was used to 
generate distance matrices in mothur. Analysis of Molecular 
Variance (AMOVA),29 as implemented by mothur, was 
then performed to determine if  any differences between the 
microbiomes of the experimental groups were statistically 
supported by differences in the distance matrix. LeFSE30 was 
used to identify OTUs differentially abundant between groups.
Minimum Entropy Decomposition (Oligotyping)
Minimum entropy decomposition was performed on the 
same samples used for the alpha and beta diversity analyses, ex-
cluding the 19 samples falling below 3076 sequences. Denoising, 
alignment, chimera removal, and taxonomy assignation were 
performed using the mothur analysis suite,24 as described 
previously. Sequences identified as belonging to the genus 
Streptococcus were then extracted and formatted using the 
“mothur2oligo” tool (available at https://github.com/michberr/
MicrobeMiseq/tree/master/mothur2oligo).
Minimum entropy decomposition analysis31 was 
performed using MED pipeline version 2.1 (available at http://
oligotyping.org/). The MED algorithm is similar to the previ-
ously described oligotyping algorithm32 and differentiates taxa 
on the basis of  single-nucleotide differences in the positions 
of  highest entropy. The parameters used were minimum sub-
stantive abundance of  a MED node (-M) = 7 and maximum 
variation allowed in each node (-V) = 4 nt. The total number 
of  Streptococcus sequences analyzed was 564,342. Of these, 
62,706 were removed as outliers due to the minimum sub-
stantive abundance parameter (-M, set to 60), and 8262 were 
removed as outliers due to the maximum variation at each node 
parameter (-V, set to 5). Thus, after the refinement, 493,374 
were analyzed and classified into 370 MED nodes (oligotypes). 
Sequences representative of  each oligotype were identified at 
species level by comparison with the Human Oral Microbiome 
database through the BLAST web tool, accessible at http://
www.homd.org.
RESULTS
A total of 1,630,578 sequences were obtained after 
denoising and quality filtering. Figure 1 shows the predomi-
nant bacterial genera found in the samples by group. For most 
individuals, the communities were dominated by the genera 
Streptococcus and Prevotella, although some subjects had no or 
very few streptococci.
The data were normalized by subsampling to a level of 
3076 sequences per sample, which excluded 19 samples from 
the subsequent analyses. Subject group sizes for the subsequent 
analyses were as follows: OFG only (74), OFG+CD (38), CD 
only (85), and HC (45). There were no significant differences be-
tween the groups for the Chao1 or inverse Simpson indices, nor 
for the average number of observed OTUs (Table 1, Kruskal 
Wallis test).
The composition of the microbial communities among 
the 4 subject groups was significantly different (AMOVA, P 
value < 0.001). Pairwise comparisons of the individual subject 
groups were performed, and CD seemed to be the primary driver 
of intergroup differences. For example, the CD only group was 
significantly different from both the HC group (P < 0.001; sig-
nificance threshold using Bonferroni correction: 0.008) and the 
OFG only group (P < 0.001). The OFG+CD group was signif-
icantly different from the HC group (P = 0.006), whereas OFG 
only was not significantly different from the HC group.
Mean age and gender distribution were not found to be 
significantly different between the 4 groups (age: Kruskal Wallis 
test; gender distribution: χ2 test). Neither immunosuppressive 
nor anti-TNF-α therapy had a significant effect on microbiome 
composition in subjects with OFG (OFG only and OFG+CD 
groups combined) (AMOVA).
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As oral disease status is known to be a major factor 
influencing oral microbiome composition, the basic periodontal 
examination was used to assess the subjects’ gingival health. 
Basic periodontal examination scores were recorded for 207 of 
the 261 subjects and were significantly different between pheno-
type groups (P < 0.001, Kruskal Wallis), as shown in Figure 2. 
Overall, there was a clear trend for subjects with OFG only to 
have higher BPE scores than HC, whereas CD only patients had 
lower BPE scores. In view of this, the effect of BPE score on 
microbiome composition was investigated. Basic periodontal 
examination scores were assigned to 3 class variables: low, ≤2; 
middle, 2–10; high, ≥10. There was no significant difference in 
microbial composition between BPE class groups by AMOVA.
The OTUs responsible for the differences in microbial 
composition seen between groups are shown in Table 2. The 
default threshold of  2 was used for the logarithmic LDA 
score for discriminative features. Eleven OTUs were found to 
be differentially represented between groups. Seven of  these 
overrepresented OTUs were over-represented in the HC group, 
suggesting that the disease phenotypes were associated with 
loss of  normal microbiota components. Most of  the differ-
entially represented OTUs were of  relatively low abundance, 
with only 3 of  them (OTU 1, 2, and 6) present in the dataset 
at a relative abundance of  greater than 0.01. Operational taxo-
nomic unit 6 was identified as Haemophilus parainfluenzae, and 
its relative abundance was significantly reduced in OFG only 
and CD only compared with HC (Fig. 3). Operational taxo-
nomic units 1 and 2 were identified as unclassified members of 
the genus Streptococcus and were the most frequently detected 
OTUs in the study, making up 17.3% and 7.8%, respectively, 
of  the oral bacterial community across all subjects. Because 
Streptococcus species vary widely in the roles that they play 
TABLE 1. Richness and Diversity of the Salivary Microbiota in Subject Groups
Subject Group n
Observed OTUs Chao1 Inverse Simpson
(sd) (sd) (sd)
OFG only 74 198.6 505.1 11.2
54.2 152.5 6.2
OFG+CD 38 183.4 449.5 9.7
57.2 125.6 4.8
HC 45 196.1 496.3 11.0
53.5 161.1 4.6
CD only 85 203.5 493.4 9.2
57.5 133.6 5.1
FIGURE 1. Box plot showing relative abundance of predominant bacterial genera by patient group. The group “under_1%” combines all genera 
present at less than 1% relative abundance.
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in oral ecology and disease, minimum entropy decomposi-
tion (MED) was used to lend more precision to species-level 
identification.
The Streptococcus sequences were binned into 370 
oligotypes that were subsequently grouped by species after 
BLAST interrogation of  the HOMD database. Where mul-
tiple species-level BLAST identifications were above 98.5% 
sequence identity, the identification was made to a group 
of  species. The mean abundances of  species and species 
groups making up more than 1% of  the total microbiota 
were compared between groups, using Wilcoxon test with 
Bonferroni correction for multiple testing. Streptococcus 
salivarius proportions were significantly higher in the OFG 
only and CD only groups compared with HC (Fig. 4). The 
S.  mitis group also showed significant differences among 
groups (Fig. 5), with healthy HC and OFG only having signif-
icantly higher relative abundances than CD only. In addition, 
the relative abundances of  individual oligotypes whose mean 
relative abundance was over 0.5% were compared across the 
groups. Three S. salivarius oligotypes were found to show sig-
nificant differences between groups (Fig. 6). Oligotype 2869 
showed the largest differences with the OFG only, CD only, 
and OFG+CD groups all having significantly higher relative 
abundance than the HC group.
DISCUSSION
The results of this study indicate that the oral microbiome 
in subjects with orofacial granulomatosis is not markedly dif-
ferent from that of healthy controls or subjects with Crohn’s 
disease because there were no differences in richness or di-
versity between the groups and all subjects had a typical oral 
microbiome compositional profile. This finding is in contrast to 
the results of numerous studies looking at the effect of CD on 
the composition of the intestinal microbiome.33 The fecal and 
mucosal microbiome is substantially altered in patients with CD. 
Richness is reduced,34, 35 and the phylum Firmicutes is relatively 
depleted, particularly anaerobes from the order Clostridiales, 
but there are raised proportions of Proteobacteria, mainly 
Enterobacteriaceae. The shift toward a less anaerobic bacterial 
community is thought to be the result of increased levels of re-
active oxygen species produced as a part of the inflammatory 
response.34 Specific genus-level microbial signatures of CD have 
been reported to be reduced levels of Faecalibacterium, an un-
known Peptostreptococcaceae, Anaerostipes, Methanobrevibacter, 
an unknown Christensenellaceae and Collinsella, and increased 
proportions of Fusobacterium and Escherichia.36
FIGURE 2. Box plot showing summed BPE scores as a proportion of the 
total microbiota. Upper and lower edges of the boxes are the first and 
third quartiles; the line inside the box is the second quartile (median); 
individual dots are outliers (** P < 0.01; *** P < 0.001; **** P < 0.0001, 
Kruskal Wallis test)
TABLE 2. OTUs Over-represented in Subject Groups (LeFSE)
Group OTU Species Over-represented Mean Relative Abundancea Log LDA
OFG only 152 Catonella morbi 0.0003 2.6
OFG+CD 065 Lachnoanaerobaculum unclassified 0.001 2.9
HC 002 Streptococcus unclassified (mitis group) 0.78 4.5
 006 Haemophilus parainfluenzae 0.044 4.1
 032 Prevotella sp. HOT-299 0.003 3.3
 037 Alloprevotella tannerae 0.002 3.1
 067 Bergeyella sp. HOT-322 0.0009 2.8
 141 Neisseria elongata 0.0004 2.6
 162 Prevotella sp. HOT-305 0.003 2.7
CD only 001 Streptococcus unclassified (salivarius group) 0.173 4.9
 047 Fusobacterium nucleatum subsp. vincentii 0.001 2.9
aall samples
D
ow
nloaded from
 https://academ
ic.oup.com
/ibdjournal/article-abstract/25/8/1367/5364052 by guest on 12 M
ay 2020
 Inflamm Bowel Dis • Volume 25, Number 8, August 2019
1372
Goel et al
Patients with OFG were found to have higher BPE scores 
than controls, although there was no corresponding difference 
in microbiome composition. The levels of BPE scores seen were 
indicative of some degree of gingival inflammation and may 
have been due to poorer oral hygiene in the patients due to the 
discomfort caused by the OFG lesions.
The lack of substantial alteration of the oral microbiome 
in OFG with or without gut CD most likely reflects the fact 
that the oral microbiome is extremely stable and not greatly af-
fected by diet37 or administration of antibiotics.38 There were, 
however, some OTUs which showed differences in relative abun-
dance between groups in the LEfSe analysis. The high number 
of comparisons performed in microbiome studies when OTU 
relative abundances are compared between patient groups can 
lead to spurious associations being revealed by chance, even 
when significance thresholds, as here, are corrected for multiple 
comparisons. Such associations should therefore be interpreted 
with caution. Of the 11 OTUs over-represented in partic-
ular subject groups, 7 were in the control group. This suggests 
that the major shift in OFG and CD was the relative loss of 
normal microbiota taxa. Another important consideration in 
interpreting OTU association analyses is whether the size of the 
effect is biologically significant. Many of the OTUs found to be 
differentially abundant were present at extremely low levels, and 
therefore, only those present at a relative abundance of greater 
than 1 % were considered further. Levels of H. parainfluenzae 
were reduced in all patient groups compared with controls. 
Haemophilus parainfluenzae is a commonly occurring member 
of the normal microbiota, and the significance of this finding 
is unclear. In contrast, proportions of oligotypes belonging to 
the S. salivarius group were found to be significantly raised in 
the OFG only and CD only groups. Streptococcus salivarius 
and related species are regarded as health-associated and are 
found primarily on the dorsum of the tongue and the pha-
ryngeal mucosa.39, 40 Indeed, strains of S.  salivarius are used 
FIGURE 4. Box plot showing summed S. salivarius group oligotypes 
as a proportion of the total microbiota. Upper and lower edges of the 
boxes are the first and third quartiles; the line inside the box is the 
second quartile (median); individual dots are outliers (*** P < 0.001; 
**** P < 0.0001, Wilcoxon test).
FIGURE 5. Box plot showing summed S. mitis group oligotypes as 
a proportion of the total microbiota. Upper and lower edges of the 
boxes are the first and third quartiles; the line inside the box is the 
second quartile (median); individual dots are outliers (*** P < 0.001, 
Wilcoxon test).
FIGURE 3. Box plot showing the relative abundance of OTU 6 
(Haemophilus parainfluenzae) as a proportion of the total microbiota. 
Upper and lower edges of the boxes are the first and third quartiles; the 
line inside the box is the second quartile (median); individual dots are 
outliers (** P < 0.01, Wilcoxon test).
D
ow
nloaded from
 https://academ
ic.oup.com
/ibdjournal/article-abstract/25/8/1367/5364052 by guest on 12 M
ay 2020
Inflamm Bowel Dis • Volume 25, Number 8, August 2019 
1373
Streptococcus Salivarius: A Potential Salivary Biomarker
as probiotics with beneficial properties against oral conditions 
such as halitosis and pharyngitis41 and have been shown to have 
anti-inflammatory properties in vitro via downregulation of the 
NF-κB pathway.42 It is not clear why the proportions of these 
species should be raised in OFG and CD, but the diseases may 
change the oral mucosa in ways which promote the adherence 
and retention of these species. It is particularly interesting that 1 
oligotype, 2869, was specifically elevated in subjects with OFG 
or CD. It is known that strains of a species can differ mark-
edly in their biological and pathogenic properties, and it seems 
that members of this oligotype, found in multiple subjects, has a 
particular and numerically strong relationship with OFG. These 
findings are of particular interest as bacterial antigens, including 
streptococci, are a known common target for Immunoglobulin 
E (IgE). And previous studies have identified infiltrates of den-
dritic B cells in the oral epithelium OFG patients which express 
surface IgE.12 Future work should be focused on confirming 
the association of specific S.  salivarius strains with OFG by 
metagenomic analyses that enable strain differentiation,43 to-
gether with the isolation of representatives of this oligotype and 
investigation of its properties of relevance to OFG.
In contrast to S. salivarius, S. mitis group organisms were 
present at lower relative abundance in the subjects with CD 
compared with OFG and controls. Streptococcus mitis is the 
commonest streptococcal species found in the human mouth.40 
The numbers of this group may have been reduced because 
proportions of S. salivarius were raised, which would have af-
fected their relative abundance.
The results of this study demonstrate that the overall com-
position of the salivary microbiota in OFG and CD was similar 
to that of healthy controls but that there were some significant—
and interesting—differences in levels of 2 of the commonest 
groups of oral streptococcal commensals, which warrant further 
investigation. In particular, S. salivarius was increased in both 
CD and OFG, whereas S. mitis decreased in CD only.
CONCLUSION
It has been previously shown that pathogenic variants 
in genes known to confer a high-risk for CD are enriched in 
OFG patients with concurrent intestinal disease (OFG+CD).44 
Furthermore, we have recently demonstrated that a useful 
toolkit for predicting intestinal inflammation in individuals at 
greatest risk for CD can be implemented from a small set of 
genetic markers, such as these, combined with family and life-
style risk factors.45 The study described here provides the first 
step in the investigation of  the utility of  salivary microbial 
biomarkers as proxy for gastrointestinal dysbiosis and disease. 
Further studies that can correlate these findings with host 
genetics, immune status, and metabolomics, and other risk 
factors could help to develop prediction tools to identify those 
OFG patients that are at greatest risk of  developing intestinal 
CD, thereby opening up the possibility for early intervention. 
In addition, a better understanding of  the interactions be-
tween microbial shifts, inflammation, and disease pathology 
would have the potential to lead to further targets for drug 
development and disease management strategies for this com-
plex phenotype.
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